IL11 and heart disorder: Notwithstanding the much more advanced complexity of human pathological cardiac fibrosis in comparison with the mouse model, our novel findings suggest an attractive possibility that targeting ALKBH5-IL-11-IL11RA1 pathway in cardiac macrophages via LNP-siRNA technology might serve as a potential therapeutic tool for the prevention of cardiac fibrosis in heart diseases.